Tag - HZNP

SVB Leerink launched coverage of Viridian Therapeutics (NASDAQ:VRDN) with an “outperform” rating and $32 price target. The stock closed at $19 on Nov. 17. Viridian is a clinical-stage biotech company focused on the...